Depleting Trim28 in adult mice is well tolerated and reduces levels of α-synuclein and tau

Alzheimer's and Parkinson's disease are late onset neurodegenerative diseases that will require therapy over decades to mitigate the effects of disease-driving proteins such tau and α-synuclein (α-Syn). Previously we found that TRIM28 regulates the levels and toxicity of α-Syn and tau (Rou...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:eLife
Huvudupphovsmän: Rousseaux, Maxime WC, Revelli, Jean-Pierre, Vázquez-Vélez, Gabriel E, Kim, Ji-Yoen, Craigen, Evelyn, Gonzales, Kristyn, Beckinghausen, Jaclyn, Zoghbi, Huda Y
Materialtyp: Artigo
Språk:Inglês
Publicerad: eLife Sciences Publications, Ltd 2018
Ämnen:
Neuroscience
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5993537/
https://ncbi.nlm.nih.gov/pubmed/29863470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.36768
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk